CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2020

Dec 2, 2020

National Storage Mechanism | Additional information

RNS Number : 2602H

Omega Diagnostics Group PLC

02 December 2020

02 December 2020

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director / PDMR Dealings

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that on 1 December 2020 Colin King, Chief Executive Officer, bought 35,721 Ordinary Shares of 4 pence each in the Company, at a price of 53.19 pence per share.

Following completion, Mr King is interested in 853,973 Ordinary Shares, representing 0.47 per cent. of the issued share capital of the Company.

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts: 

Omega Diagnostics Group PLC	Tel: 01259 763 030
Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Teddy Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Colin King

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Omega Diagnostics Group Plc

b)

LEI:

2138007U9P4BTZTYIR92

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 4 pence each

GB00B1VCP282

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)	Volume(s)
£0.5319	35,721

d)

Aggregated information:

·    Aggregated volume:

·    Price:

Single transaction as in 4 c) above

Price(s)	Volume(s)
£0.5319	35,721

e)

Date of the transaction:

1 December 2020

f)

Place of the transaction:

LSE

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGIBDDSSGDGGD